Targeting Stem Cells in Chronic Inflammatory Diseases
Mari van de Vyver1, Yigael S L Powrie2,3, Carine Smith3
1Department of Medicine, Faculty of Medicine & Health Sciences, Stellenbosch University, Cape Town, South Africa. vandevyverm@sun.ac.za.
Advances in Experimental Medicine and Biology
|March 16, 2021
Summary
Mesenchymal stem cell (MSC) dysfunction worsens type 2 diabetes. Rejuvenating MSCs with anti-inflammatory agents, antioxidants, or biological therapies shows promise for improving healing and quality of life in diabetic patients.
Area of Science:
- Gerontology
- Immunology
- Regenerative Medicine
Background:
- Mesenchymal stem cell (MSC) dysfunction is linked to aging and type 2 diabetes.
- Inflammation and oxidative stress cause cellular senescence, impairing MSC immunomodulatory and regenerative functions, worsening disease severity and comorbidities.
Purpose of the Study:
- To review MSC dysregulation in diabetes mellitus.
- To explore intervention strategies for MSC rejuvenation and functional restoration.
Main Methods:
- Literature review focusing on therapeutic interventions for MSC dysfunction.
- Discussion of pharmacological (NFκB antagonists), natural (phytomedicine), and biological (exosomes, probiotics) agents.
- Consideration of methodological challenges for in vivo applications.
Main Results:
- In vitro studies indicate anti-inflammatory agents, antioxidants, and biological agents can revitalize MSCs.
- These interventions hold potential for improving MSC function in the context of diabetes.
Conclusions:
- Targeting stem/progenitor cells to restore function can improve healing outcomes and quality of life for diabetic patients.
- An integrated systems approach and understanding of disease pathology are crucial for identifying effective in vivo therapeutic candidates.
Related Concept Videos
Regulation of Hematopoietic Stem Cells
3.6K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.6K
Stem Cell Therapy for Tissue Regeneration
4.4K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.4K
Mesenchymal Stem Cells
5.2K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.2K
Stem Cell Culture
5.8K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.8K
T Cell Types and Functions
1.7K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.7K
iPS Cell Differentiation
2.9K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.9K


